CN
HOME>Company News>MEDLAB 2025 | Uni-medica shines at Dubai

MEDLAB 2025 | Uni-medica shines at Dubai

2025-02-08

From February 3 to 6, 2025, the Dubai International Laboratory Equipment Exhibition (Medlab Middle East) will be held at the Dubai International Convention and Exhibition Center in the United Arab Emirates. This exhibition is the largest in the medical device field in the Middle East and is also one of the most influential exhibitions in the world. It will gather 747 exhibitors from 48 countries to showcase the latest products and technologies, including 201 exhibitors from China, and is expected to attract nearly 30,000 professional visitors who will witness the latest products and cutting-edge technologies.

PRODUCT


Uni-medica, a company focused on the research and development of products for infection and maternal and child health, showcased its gynecological fluorescence scanning image analysis system and several molecular diagnostic products for infections, including HPV testing products, at this exhibition, shining at the venue and receiving unanimous praise from numerous industry experts worldwide.


  VIEW








About Uni-medica


Shenzhen Uni-medica Technology Co., Ltd (Uni-medica) is a national high-tech enterprise. It has established cooperation and jointly performed a number of scientific research projects with the Hong Kong University of Science and Technology, Shenzhen University and Chinese Academy of Sciences. Uni-medica was also selected as one of the top 100 new Chinese innovative enterprises. 


The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R&D and industrialization  of molecular diagnostic products aiming at prevention and control of infectious diseases and genetic diseases.


Uni-medica provides total solution of accurate diagnosis of infectious diseases and genetic diseases based on multi-omics technologies, including multiplex PCR, NGS technology and flow cytometry.


Uni-medica is qualified by ISO 13485 and NMPA quality control system. The pathogen molecular detection products are daily used in hundreds of hospitals, Centers for Disease Control and Prevention and Quarantine Laboratories throughout the country, providing strong support for prevention and control of infectious diseases.

Message